Rivaroxaban

name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary...

ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery |

Johnson & Johnson and Bayer's legacy blood thinner Xarelto has had a tough year with competitors picking up steam and prescriptions leveling off.

FDA clears Xarelto blood thinner despite faulty trial device

The U.S. Food and Drug Administration on Tuesday said it has determined the widely-used blood thinner Xarelto to be safe and effective for patients with the heart condition atrial fibrillation afte...

Anticoagulant

a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches...

Blood Thinner Basics

Your doctor may prescribe a blood thinner to help prevent... Rivaroxaban (Xarelto) Warfarin (Coumadin, Jantoven)... forming new clots. They also slow the growth of existing clots....

Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New Yor....

Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million The settlement resolves about 25,000 lawsuits, which claimed the companies failed to warn about...

New blood thinner 'antidote' to help doctors move past warfarin

A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that can reverse the medications' effects in an emergency is expected to enter...

When will NOAC reversal agents be available in Korea? < Pharma < Article

Several drugs that reverse the blood thinning effect of non-vitamin K oral anticoagulants (NOAC) have arrived in the global market, but it will take some time for Korean physicians to use them, experts said. Representative NOAC reversal agents are used against Pradaxa (ingredient: dabigatran), Eliquis (apixaban), and Xarelto (rivaroxaban). The NOAC market has expanded rapidly as NOACs lowered the bleeding risk in stroke prevention treatment for atrial fibrillation patients, compared to warfarin....

Some increased bleeding risk seen with blood thinner Xarelto vs. Pradaxa

The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with atrial fibrillation, new research suggests.

Are there supplements I should avoid when taking apixaban (Eliquis) or similar blood thinner drugs like X....

Learn about supplement interactions with apixaban (Eliquis), rivaroxaban (Xarelto) and other blood thinner drugs in the direct factor Xa inhibitors class.